Edit Entry | Edit CV

Alan J Budney, PhD

Professor of Psychiatry
Professor of Biomedical Data Science

Additional Titles/Positions/Affiliations
Director, T32 Predoctoral and Postdoctoral Training Program in the Science of Co-occurring Disorders

Director, Treatment Development and Evaluation Core, Center for Technology and Behavioral Health (P30 Center of Excellence - Marsch, PI)

Biomedical Data Science

Postdoctoral Fellowship, Substance Abuse and Behavioral Pharmacology, University of Vermont (1990-93)
Ph.D., Clinical Psychology, Rutgers University (1989)
B.S., Psychology with Honors, Pennsylvania State University (1981)


Academic Analytics
View Profile

Contact Information

Geisel School of Medicine at Dartmouth
Center for Technology and Behavioral Health
46 Centerra Pkwy, Suite 315, HB 7255
Lebanon, NH 03766

Office: 603-646-7088
Phone: 501-626-6568
Email: Alan.J.Budney@Dartmouth.edu

Professional Interests

Prevention and Intervention; Treatment Development; Marijuana / Cannabis Pharmacology, Phenomenology, Regulatory Science; Substance Use Etiology.

Grant Information

T32DA037202-07 Budney (PI) 07/01/2019 - 6/30/2024
NIH/NIDA: Science of Co-Occurring Disorders
This training award supports the training of 4 postdoctoral and 3 pre-doctoral trainees. Training focuses on the development of researchers interested in the co-occurrence of substance use disorders and other types of related mental or physical health conditions. Areas of research range from neuroscience to health services.

R01DA050032-01 Budney (PI) 09/30/2020-07/31/2025
NIH/NIDA: Leveraging Social Media to Develop the Cannabis Exposure Index (CEI), A
Standardized Measure of Cannabis Use
This project will develop and validate a measure of cannabis consumption that will enhance the capacities of clinical, epidemiologic and policy studies and lead to more informed communication about cannabis and its risks to clinicians, health educators and policy makers.

P30DA029926-10 Marsch (PI) 07/01/2011 – 05/31/2021
NIH/NIDA: Technology-based Treatments for Substance Use Disorders
This P30 “Center of Excellence” grant supports a research center focused on research and development activities that systematically combine science-based behavior change interventions with state-of-the-science technologies to create, evaluate, and disseminate digital therapeutics targeting substance use disorders and related issues (including HIV risk behavior and mental health conditions).
Role: Director, Treatment and Development Core

R01DA027232 Al'absi (PI) 09/01/2017-06/30/2021
NIH/NIDA: Effect of sex differences and concurrent cannabis use on stress-related psychobiological mechanisms associated with smoking cessation and relapse
This project will use novel stress-related measures and focus on sex differences in effects of concurrent cannabis use in smokers interested in tobacco cessation. Role: Co-I

R01 DA044670 Barrington; Leventhal (MPI) 09/20/2019-08/31/2024
NCI: Vaping Nicotine and Cannabis Across Adolescence and Young Adulthood.
This study will provide new essential information about whether low-risk AYAs begin nicotine and cannabis use via vaping, and whether vaping may lead to adverse consequences, including cigarette and cannabis smoking. Role: Co-I

1UG1DA040309-06 Marsch ( PI) 07/1/2015 - 02/28/2025
Northeast Node of the National Drug Abuse Clinical Trials Network
The Northeast Node reflects a research partnership in which NIDA, researchers, and community-based providers develop, evaluate, and disseminate new prevention and treatment options for substance use disorders in community-based medical settings in Maine, New Hampshire, and Vermont. Role: Co-I

K23DA042130 Montgomery (PI) 08/15/2017-07/31/2022
NIH/NIDA: Twitter-Based Intervention for Young Adult African American Blunt Smokers.
This project involves the development and evaluation of a low-cost, fully automated and accessible internet-based social media (i.e., Twitter) treatment intervention to help reduce blunt use among young African American adults. Role: Co-Mentor

K01DA046697 Meacham 04/01/2019-03/31/2024
NIH/NIDA: Using Digital Tools to Understand Contexts and Consequences of High-THC Cannabis Use.
This project will provide much needed information on emerging cannabis products and methods of use, perceived and experienced health risks, and existing digital health resources. Role: Co-Mentor

5K01DA047912 Okafor 08/01/2019-07/31/2024
NIH/NIDA: The impact of cannabinoids on inflammation, HIV viral load and symptoms of distress among persons living with HIV.
Findings from this study will provide timely data on the impact of THC and CBD on symptoms of distress, inflammation and HIV viral load in persons living with HIV. Role: Co-Mentor

Mentoring Information

Current Postdoctoral Fellow: Cara Struble, Ph.D (Wayne State)

Current Graduate Student:

Selected Publications


Evaluating preferences for medication formulation and treatment model among people who use opioids non-medically: A web-based cross-sectional study.
Saunders EC, Budney AJ, Cavazos-Rehg P, Scherer E, Bell K, John D, Marsch LA
J Subst Use Addict Treat. 2024 Aug;163:209383. doi: 10.1016/j.josat.2024.209383. Epub 2024 Apr 24.
PMID: 38670531

Age differences in patterns of cannabis use among an online US sample of adults who consume cannabis frequently.
Livne O, Budney A, Borodovsky J, Shmulewitz D, Walsh C, Struble CA, Habib M, Aharonovich E, Hasin DS
Am J Drug Alcohol Abuse. 2024 Mar 3;50(2):242-251. doi: 10.1080/00952990.2024.2309340. Epub 2024 Apr 19.
PMID: 38640463

Impact of Early-Life Adversity on Cannabis Use: Exploring the Mediating and Moderating Effects of Chronic Pain.
Hodges JS, DeAngelis BN, Borodovsky J, Budney A, al'Absi M
Cannabis Cannabinoid Res. 2024 Mar 18; doi: 10.1089/can.2023.0218. Epub 2024 Mar 18.
PMID: 38498016

Development of Mobile Contingency Management for Cannabis Use Reduction.
Beckham JC, Calhoun PS, Chen Z, Dennis MF, Kirby AC, Treis ET, Hertzberg JS, Hair LP, Mann AJ, Budney AJ, Kimbrel NA
Behav Ther. 2024 Jan;55(1):1-13. doi: 10.1016/j.beth.2023.03.004. Epub 2023 Apr 5.
PMID: 38216224

Biobehavioral and affective stress responses during nicotine withdrawal: Influence of regular cannabis co-use.
al'Absi M, DeAngelis BN, Nakajima M, Hodges JS, Budney A, Hatsukami D, Allen S
Psychopharmacology (Berl). 2024 Feb;241(2):253-262. doi: 10.1007/s00213-023-06481-w. Epub 2023 Oct 28.
PMID: 37897498

Early life adversity and substance use: The mediating role of mood and the moderating role of impulsivity.
al'Absi M, DeAngelis B, Borodovsky J, Sofis MJ, Fiecas M, Budney A
J Psychiatr Res. 2023 Dec;168:38-44. doi: 10.1016/j.jpsychires.2023.10.008. Epub 2023 Oct 6.
PMID: 37883864

Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder.
Lee DC, Schlienz NJ, Herrmann ES, Martin EL, Leoutsakos J, Budney AJ, Smith MT, Tompkins DA, Hampson AJ, Vandrey R
J Subst Use Addict Treat. 2024 Jan;156:209180. doi: 10.1016/j.josat.2023.209180. Epub 2023 Oct 5.
PMID: 37802317

Exploring survey methods for measuring consumption quantities of cannabis flower and concentrate products.
Borodovsky JT, Struble CA, Habib MI, Hasin DS, Shmulewitz D, Walsh C, Livne O, Aharonovich E, Budney AJ
Am J Drug Alcohol Abuse. 2023 Nov 2;49(6):733-745. doi: 10.1080/00952990.2023.2246635. Epub 2023 Dec 11.
PMID: 37774316

Evaluating age-related disparities in cannabis-related problems among LGBT+ versus non-LGBT+ adults.
Struble CA, Borodovsky JT, Habib MI, Livne O, Walsh CA, Aharonovich E, Hasin DS, Budney AJ
Addict Behav. 2024 Jan;148:107861. doi: 10.1016/j.addbeh.2023.107861. Epub 2023 Sep 14.
PMID: 37748224

Extending Gender- and Sex-Based Analyses in Cannabis Research: Findings from an Online Sample of Gender Diverse Young Adult Consumers.
Struble CA, Borodovsky JT, Habib MI, Hasin DS, Shmulewitz D, Livne O, Walsh C, Aharonovich E, Budney AJ
Cannabis Cannabinoid Res. 2023 Aug 18; doi: 10.1089/can.2023.0069. Epub 2023 Aug 18.
PMID: 37594777

View more publications on PubMed